Xuemei Li

First-Line Nivolumab Plus Ipilimumab in Advanced Non–Small-Cell Lung Cancer (CheckMate 568): Outcomes by Programmed Death Ligand 1 and Tumor Mutational Burden as Biomarkers

Neal Ready, Matthew D. Hellmann, Mark M. Awad et al. · Journal of Clinical Oncology · 2019 · 596 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17

Major vascular involvement in Behçet’s disease: a retrospective study of 796 patients

Yunyun Fei, Xuemei Li, Sen Lin et al. · Clinical Rheumatology · 2013 · 130 citations

Medicine, Immunology, Pathology +9

Conservation of Carbohydrate Binding Interfaces — Evidence of Human HBGA Selection in Norovirus Evolution

Ming Tan, Ming Xia, Yutao Chen et al. · PLoS ONE · 2009 · 117 citations · Full text

Life Sciences, Biology, Infectious Diseases +17

Sex disparities in clinical characteristics and prognosis of immunoglobulin G4–related disease: a prospective study of 403 patients

Liwen Wang, Panpan Zhang, Xia Zhang et al. · Lara D. Veeken · 2018 · 103 citations

Life Sciences, Immunology, Internal Medicine +15

2020 Chinese guidelines for the diagnosis and treatment of systemic lupus erythematosus

Mengtao Li, Yan Zhao, Zhiyi Zhang et al. · Rheumatology and Immunology Research · 2020 · 77 citations · Full text

Life Sciences, Internal Medicine, Pharmacotherapy +17